SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors aggressively position for the pending 80th event trigger in its REGAL Phase 3 trial, a key milestone that could unblind survival data and ignite M&A interest from major pharmaceutical players. Community sentiment is polarized between long-term investors tracking clinical math and active short sellers struggling with rising borrow costs and high margin requirements as the market awaits definitive topline results.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is attracting significant community attention as investors position themselves for upcoming Ethereum mainnet integration and potential regulatory catalysts that could drive institutional liquidity into the Base ecosystem. While traders are actively debating price floors and accumulation strategies, discussion is heavily focused on the protocol's sustained revenue generation compared to other decentralized exchanges.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following an earnings report that showcased robust revenue growth and an optimistic outlook, fueling significant retail and institutional interest. Community sentiment is deeply divided between long-term investors highlighting the stock's pivot into AI-powered semiconductor technology and skeptics cautioning that the current rally may invite a share offering or a classic post-hype retracement.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to rising investor focus on its upcoming earnings report and the broader implications of its Valaris merger in a constrained offshore drilling market. The community is actively debating the stock's valuation and debt reduction progress against a backdrop of geopolitical tensions in the Middle East that continue to affect global energy supplies.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility, fueled by active community debates over potential short squeezes and speculation regarding whale accumulation versus ongoing pump-and-dump concerns. Investors are closely monitoring volume patterns and price support levels, often comparing current market behavior to previous rapid run-ups in the token.

TOSHI

TOSHI is trending as investors highlight its status as a major Base network asset and discuss recent AI-driven utility integrations. The community is actively debating the project's long-term potential, focusing on buyback and lock mechanisms while expressing both frustration with recent price action and optimism for a future rally.

Chip

Community sentiment remains polarized as traders debate whether the project is a legitimate infrastructure play for GPU-backed financing or a volatile asset prone to insider selling. Investors are closely monitoring volume spikes and protocol activity as they look for catalysts to break through recent technical resistance levels.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing intense community debate over a potential buyout versus the risks of independent commercialization, as investors look ahead to upcoming Phase 1 maintenance trial results. While some shareholders are frustrated by the stock's recent performance relative to the broader biotech sector, others remain focused on the company's strong pipeline and the long-term potential of its GLP-1 assets to disrupt the obesity market.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing significant market interest and institutional attention due to its official inclusion in the Nasdaq-100 index, a move that mandates buying by index-tracking funds. The community is actively debating the company's valuation relative to its massive contract backlog and AI infrastructure buildout, while contrasting its growth trajectory with sector peers amid ongoing discussions about insider selling and debt levels.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors anticipate the upcoming Phase 3 trial launch for its NSCLC program, which many believe will shift market perception from a single-asset company to a multi-indication oncology platform. Community sentiment remains highly bullish, with significant discussion focused on the stock's low valuation relative to its clinical progress, the tightness of the float, and the high potential for a lucrative partnership or buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe Karooooo (KARO) Could Rally 33.07%: Here's is How to Trade

The consensus price target hints at a 33.1% upside potential for Karooooo (KARO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here is Why Growth Investors Should Buy Karooooo (KARO) Now 

Karooooo (KARO) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Karooooo Ltd. Group CEO Zak Calisto Featured on Water Tower Research Small-Cap Spotlight

Karooooo Ltd. (NASDAQ: KARO), a global provider of mobility and operational intelligence solutions, today announced that Zak Calisto, Founder, Chairman, and Chief Executive Officer, was featured on Water Tower Researchs Small-Cap Spotlight. The episode was hosted by Tim Gerdeman, Host at Water...

Karooooo: A Strong Contender in Fleet Management with Room to Grow

Explore the exciting world of Karooooo (NASDAQ: KARO) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of...

Looking for a Growth Stock? 3 Reasons Why Karooooo (KARO) is a Solid Choice 

Karooooo (KARO) Q4 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Karooooo Q4 Earnings Call Highlights

Karooooo Ltd. (KARO) Lags Q4 Earnings Estimates

Karooooo (KARO) delivered earnings and revenue surprises of -14.28% and +1.59%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

Datadog (DDOG) Q1 Earnings and Revenues Top Estimates

Datadog (DDOG) delivered earnings and revenue surprises of +19.14% and +5.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Karooooo Ltd. (NASDAQ:KARO) Given Consensus Rating of "Moderate Buy" by Analysts

Karooooo Ltd. (NASDAQ:KARO - Get Free Report) has been given a consensus rating of 'Moderate Buy' by the seven analysts that are covering the stock, Marketbeat.com reports. One investment analyst has...

Karooooo Ltd. engages in providing mobility data analytics solutions for the transportation industry. It operates through the following business segments: Cartrack, Carzuka, and Karooooo Logistics. The Cartrack segment provides an on-the-ground operational Internet of Things Software-as-a-service cloud. The Carzuka segment refers to a physical and e-commerce vehicle buying and selling marketplace. The Karooooo Logistics segment offers software applications enabling the management of last mile delivery and general operational logistics. It also operates through the South Africa, Africa-Other, Europe, and Asia-Pacific Middle East and U.S.A geographical segments. The company was founded on May 19, 2018 and is headquartered in Singapore.

Karooooo Ltd

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.53	--	--	N/A
Q4 '25	$0.51	$0.44	-14.32%	MISSED
Q3 '25	$0.48	$0.52	8.29%	BEAT
Q2 '25	$0.46	$0.50	10.75%	BEAT
Q1 '25	$0.42	$0.49	16.87%	BEAT

KAROKarooooo Ltd

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest KARO News